Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY versus Menactra in healthy children aged 2 to 10 years
2014-005161-72Phase 3
- Sponsor
- Novartis
- Start
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Meningococcal ACWY conjugate vaccine, meningococcal A conjugate vaccine in meningococcal disease, sponsored by Novartis.
02
Drugs
Meningococcal ACWY conjugate vaccinemeningococcal A conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2014-005161-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005161-72.